Oncology nurses can play a key role in educating patients and supporting clinical trial participation for this new treatment ...

DelveInsight’s Anaplastic Thyroid Cancer Pipeline report depicts a robust space with 8+ active players working to develop 8+ ...

Dr Amit Rauthan, Head, Department and Consultant, Medical Oncology and Hemato-Oncology, Manipal Hospital, explains how the advancements in oncology are offering hope by transforming cancer into a more ...

SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

Originally designed as glucose-lowering medications, SGLT2 inhibitors provide benefits across the cardio-renal-metabolic ...

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are under review.

The firm will assess irpagratinib plus best supportive care in patients with FGF19-overexpressing advanced liver cancer.